ClinicalTrials.gg

Enovis clinical trials

Also known as Colfax.

The registry lists 62 studies whose lead sponsor is Enovis or one of 6 companies grouped under it. 14 are recruiting or about to start. Per ClinicalTrials.gov, last updated Oct 28, 2026.

Our grouping of 6 registry names, not the registry’s. See them and correct one ↓

Get an email when these change. Save the Enovis studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Coming up

5 of Enovis’s studies under way reach primary completion within a year. The dates are the sponsor’s own estimates, which often move.

Phase 3 Other phases

  1. N’26
  2. D
  3. J’27
  4. 1F
  5. M
  6. 1A
  7. 1M
  8. 1J
  9. J
  10. A
  11. S
  12. 1O
  13. N

Add all 5 to your calendar (.ics) → With an account.

All 62 at a glance

Where each study is in its life, its phase and its countries. Each count opens them in search.

  • Open now1423%Recruiting 9 · Not yet recruiting 4 · Enrolling by invitation 1
  • Under way, not recruiting35%
  • Completed2235%
  • Stopped early1118%Terminated 10 · Withdrawn 1
  • Status unknown or other1219%

Phase

  • Phase 32
  • Phase 41

Where

  • United States31
  • Italy11
  • United Kingdom7
  • Slovakia4
  • Belgium2
  • France2

Over the years

  1. 07
  2. 08
  3. 09
  4. 10
  5. 11
  6. 12
  7. 13
  8. 14
  9. 15
  10. 16
  11. 17
  12. 18
  13. 19
  14. 20
  15. 1021
  16. 22
  17. 23
  18. 24
  19. 25
  20. 126

By the year each study started; 4 started before 2007. 2026 so far in the lighter column.

Registry sponsor names on this page

Our grouping. This page groups the registry's lead sponsor names by company — our grouping, not the registry's. It can be wrong or incomplete: an acquired company whose name never mentions its owner may be missing. Use “Something wrong?” under any name below to correct it.

Tell us about a missing company
No account needed. Please leave out personal details.

Each name exactly as ClinicalTrials.gov lists it, and how it relates to Enovis.

  • Limacorporate S.p.a
    Acquired — became part of Enovis, Jan 3, 2024 · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    31 studies →
  • Encore Medical, L.P.
    Acquired — became part of Enovis, Feb 22, 2019 · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    21 studies →
  • MedShape, Inc
    Acquired — became part of Enovis, Apr 23, 2021 · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    6 studies →
  • Novastep
    Acquired — became part of Enovis, Jun 28, 2023 · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    2 studies →
  • LiteCure LLC
    Acquired — became part of Enovis, 2020 · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    1 study →
  • Empi, A DJO Company
    Acquired — became part of Enovis, Feb 22, 2019 · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    1 study →

Focus areas

Conditions Enovis leads ten or more studies in, by study count. A broader condition is left out when almost all its studies are already in a narrower one listed here.

Studies

Recruiting first, then most recently updated. Showing 50 of 62. Browse all 62 →